Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine
· Delayed Price · Currency is JOD · Price in USD 4.000
0.00 (0.00%)
At close: Dec 1, 2025
PEX:BPC Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 110 | 120 | 120 | 121 | 78 | 73 | Upgrade
|
| Market Cap Growth | -2.55% | -0.56% | -0.94% | 56.41% | 6.71% | 1.34% | Upgrade
|
| Enterprise Value | 107 | 111 | 109 | 111 | 72 | 70 | Upgrade
|
| Last Close Price | 2.84 | 3.04 | 3.02 | 2.98 | 1.88 | 1.71 | Upgrade
|
| PE Ratio | 12.07 | 32.54 | 27.70 | 21.51 | 9.07 | 13.93 | Upgrade
|
| PS Ratio | 3.33 | 4.15 | 3.93 | 3.64 | 2.41 | 2.86 | Upgrade
|
| PB Ratio | 1.41 | 1.61 | 1.61 | 1.65 | 1.18 | 1.29 | Upgrade
|
| P/TBV Ratio | 1.42 | 1.62 | 1.62 | 1.67 | 1.19 | 1.30 | Upgrade
|
| P/FCF Ratio | 74.67 | 31.03 | 19.18 | 105.72 | 40.29 | 20.01 | Upgrade
|
| P/OCF Ratio | 31.69 | 24.23 | 13.93 | 32.84 | 30.02 | 18.22 | Upgrade
|
| EV/Sales Ratio | 3.25 | 3.85 | 3.55 | 3.34 | 2.23 | 2.76 | Upgrade
|
| EV/EBITDA Ratio | 14.63 | 17.27 | 17.63 | 13.99 | 8.45 | 11.54 | Upgrade
|
| EV/EBIT Ratio | 16.94 | 20.47 | 21.30 | 16.42 | 9.82 | 14.37 | Upgrade
|
| EV/FCF Ratio | 72.96 | 28.78 | 17.32 | 97.07 | 37.24 | 19.28 | Upgrade
|
| Debt / Equity Ratio | - | - | - | 0.01 | 0.02 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 0.11 | 0.17 | 0.37 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.75 | 0.75 | 0.62 | Upgrade
|
| Asset Turnover | 0.37 | 0.32 | 0.35 | 0.40 | 0.43 | 0.36 | Upgrade
|
| Inventory Turnover | 2.37 | 2.20 | 2.22 | 2.53 | 2.36 | 1.83 | Upgrade
|
| Quick Ratio | 4.61 | 4.48 | 6.58 | 7.15 | 6.51 | 5.01 | Upgrade
|
| Current Ratio | 5.95 | 5.45 | 8.22 | 9.01 | 8.31 | 6.85 | Upgrade
|
| Return on Equity (ROE) | 12.16% | 4.94% | 5.90% | 8.08% | 14.10% | 9.31% | Upgrade
|
| Return on Assets (ROA) | 4.39% | 3.76% | 3.62% | 5.08% | 6.11% | 4.36% | Upgrade
|
| Return on Capital (ROIC) | 5.33% | 4.55% | 4.28% | 5.99% | 7.25% | 5.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.30% | 6.60% | 6.10% | 8.30% | 9.80% | 7.50% | Upgrade
|
| Earnings Yield | 8.27% | 3.07% | 3.61% | 4.65% | 11.03% | 7.18% | Upgrade
|
| FCF Yield | 1.34% | 3.22% | 5.21% | 0.95% | 2.48% | 5.00% | Upgrade
|
| Dividend Yield | 1.25% | 1.17% | 1.17% | 2.39% | 1.89% | 3.05% | Upgrade
|
| Payout Ratio | 15.11% | 37.40% | 63.39% | 24.39% | 23.60% | 56.73% | Upgrade
|
| Buyback Yield / Dilution | - | - | -2.30% | 2.38% | - | - | Upgrade
|
| Total Shareholder Return | 1.25% | 1.17% | -1.12% | 4.76% | 1.89% | 3.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.